Under the agreement, Evonik will distribute InVitria’s blood-free rHSA portfolio to its biopharma customers
Building a transparent, data-driven supply chain and self-reliant API ecosystem remains critical to reducing import dependence
The event will be attended by 35,000+ industry professionals
The company's net income attributable to equity holders dropped to €2.80 billion from €2.82 billion last year
Telangana aims to increase the value of the Life Sciences economy from US$ 80 billion to US$ 250 billion by 2030
Vaccine efficacy against primary CMV infection ranged from 6 per cent to 23 per cent, depending on case definition, falling short of Moderna’s predefined target
Several technologies for hemoglobinopathies are being transferred to commercial partners
Panacea Biotec receives acceptance from CMSS for supply of bOPV
Conventional plasmids as a pharmaceutical material are not only suboptimal in safety and function, but exceedingly costly to produce, prohibitively
Early stage projects of up to Rs. 9 crore eligible for up to Rs. 5 crore assistance and later stage projects of up to Rs. 285 crore eligible for up to Rs. 100 crore assistance
Subscribe To Our Newsletter & Stay Updated
